We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+12.21%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$290M
AUM Growth
+$16.2M
Cap. Flow
-$4.34M
Cap. Flow %
-1.5%
Top 10 Hldgs %
25.51%
Holding
174
New
37
Increased
46
Reduced
48
Closed
32

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.3M
2
GEV icon
GE Vernova
GEV
+$2.82M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$2.76M
4
DYN icon
Dyne Therapeutics
DYN
+$2.61M
5
AMZN icon
Amazon
AMZN
+$2.59M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$6M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$4.02M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$3.97M
4
MRUS
Merus
MRUS
+$2.23M
5
META icon
Meta Platforms (Facebook)
META
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 46.45%
2 Technology 15.69%
3 Consumer Discretionary 9.1%
4 Industrials 4.98%
5 Financials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SE icon
51
Sea Limited
SE
$80.5B
$1.88M 0.65%
19,941
+600
+3% +$45.3K
RTX icon
52
RTX Corp
RTX
$302B
$1.87M 0.64%
15,400
-2,100
-12% -$240K
KNSA icon
53
Kiniksa Pharmaceuticals
KNSA
$6.07B
$1.87M 0.64%
74,639
-14,049
-16% -$342K
V icon
54
Visa
V
$677B
$1.85M 0.64%
6,727
-2,200
-25% -$595K
CATX icon
55
Perspective Therapeutics
CATX
$363M
$1.85M 0.64%
138,350
+24,800
+22% +$330K
HPE icon
56
Hewlett Packard
HPE
$72B
$1.82M 0.63%
+88,900
New +$1.7M
DVAX
57
DELISTED
Dynavax Technologies
DVAX
$1.81M 0.63%
162,708
+6,547
+4% +$72.2K
LQDA icon
58
Liquidia Corp
LQDA
$7.83B
$1.81M 0.62%
180,947
+59,193
+49% +$647K
FISV
59
Fiserv Inc
FISV
$28B
$1.81M 0.62%
10,053
-5,500
-35% -$907K
TSM icon
60
TSMC
TSM
$2.19T
$1.79M 0.62%
+10,300
New +$1.76M
INTU icon
61
Intuit
INTU
$92B
$1.78M 0.61%
2,863
-2,000
-41% -$1.28M
BBIO icon
62
BridgeBio Pharma
BBIO
$16.4B
$1.76M 0.61%
69,054
+24,482
+55% +$643K
HDB icon
63
HDFC Bank
HDB
$120B
$1.72M 0.59%
54,882
+4,800
+10% +$148K
IBN icon
64
ICICI Bank
IBN
$107B
$1.71M 0.59%
57,447
+5,300
+10% +$154K
STX icon
65
Seagate
STX
$186B
$1.71M 0.59%
15,600
-2,200
-12% -$225K
WDC icon
66
Western Digital
WDC
$151B
$1.71M 0.59%
33,075
+1,852
+6% +$93.6K
CSCO icon
67
Cisco
CSCO
$475B
$1.7M 0.59%
+31,900
New +$1.55M
OFIX icon
68
Orthofix Medical
OFIX
$420M
$1.69M 0.58%
+108,100
New +$1.73M
GDX icon
69
VanEck Gold Miners ETF
GDX
$27.5B
$1.67M 0.58%
42,000
-4,200
-9% -$159K
AER icon
70
AerCap
AER
$23.5B
$1.61M 0.56%
17,000
+1,400
+9% +$131K
STNE icon
71
StoneCo
STNE
$2.42B
$1.6M 0.55%
141,930
+46,800
+49% +$597K
NU icon
72
Nu Holdings
NU
$65.9B
$1.59M 0.55%
116,761
-4,300
-4% -$57.9K
LYV icon
73
Live Nation Entertainment
LYV
$42.7B
$1.58M 0.54%
14,400
-200
-1% -$19.3K
CORZ icon
74
Core Scientific
CORZ
$6.35B
$1.58M 0.54%
+132,800
New +$1.38M
BBD icon
75
Banco Bradesco
BBD
$35B
$1.56M 0.54%
585,400
+48,300
+9% +$124K
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2024 Portfolio in Review

As of Q3 2024, HighVista Strategies held 174 positions worth $290M, up 5.9% from $274M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

HighVista Strategies's Q3 2024 filing shows 37 new, 46 increased, 48 reduced and 32 closed positions. Its largest new stake was Amgen: 10,101 shares worth $3.25M. The largest sale was Insmed, an estimated $6M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Consumer Discretionary.

  • HighVista Strategies's largest Q3 2024 buy was Amgen: 10,101 shares worth $3.25M.
  • HighVista Strategies added most to Protagonist Therapeutics in Q3 2024, an estimated $2.76M increase.
  • HighVista Strategies's biggest Q3 2024 reduction was Insmed, cutting an estimated $6M.
  • HighVista Strategies fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $4.02M.
  • HighVista Strategies's ten largest holdings make up 26% of its $290M portfolio in Q3 2024.
  • HighVista Strategies opened 37 new positions and closed 32 in Q3 2024.
  • HighVista Strategies's portfolio value rose 5.9% quarter-over-quarter to $290M.

Based on HighVista Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.